Gaudium IVF and Women Health Limited, recognised as India’s first publicly listed IVF chain, announced the opening of a new fertility centre in South Delhi. The centre marks the inaugural milestone of the company’s roadmap to establish a total of 19 centres across the country, as outlined to investors during its IPO. Central to the facility is the proprietary Gaudium Signature Lab, a laboratory framework that blends advanced embryology with AI‑powered technologies and internationally benchmarked quality standards, creating an optimal environment for embryo development. The AI‑assisted embryology ecosystem deployed at the centre includes the SiD (Sperm Identification Device) for detailed sperm assessment and ERICA (Embryo Ranking Intelligent Classification Assistant) for data‑driven embryo evaluation, tools designed to augment embryologists’ expertise with precise, consistent insights throughout the IVF process. The South Delhi location offers comprehensive fertility care under one roof, integrating experienced fertility specialists, advanced reproductive medicine protocols, and the standardised clinical procedures that define Gaudium IVF’s service model. The company’s 17‑year legacy of innovation and patient‑centric care has been recognised internationally through the European Quality Award from ESQR, Spain, underscoring the high laboratory standards that support its clinical outcomes, including complex infertility and recurrent IVF failure cases. Chairperson and Managing Director Dr. Manika Khanna stated that the launch reflects Gaudium IVF’s commitment to delivering world‑class, technology‑driven fertility care that is transparent, compassionate, and tailored to individual patient needs, and that the Signature Lab model will be replicated across all future centres to ensure uniform precision, safety, and clinical excellence. The announcement comes amid rising demand for specialised fertility services in India, driven by delayed parenthood, evolving lifestyles, and greater awareness of assisted reproductive technologies. By scaling its AI‑enabled, standardised laboratory model, Gaudium IVF aims to make high‑quality fertility care more accessible nationwide, reinforcing its leadership in the rapidly evolving Indian fertility sector.